Abrupt visual loss during anti-vascular endothelial growth factor treatment for type 3 neovascularization

AIM: To investigate the incidence of abrupt visual loss and its associated factors, during anti-vascular endothelial growth factor (VEGF) treatment for type 3 neovascularization. METHODS: This retrospective study included 137 eyes that were newly diagnosed with type 3 neovascularization. All eyes we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Ophthalmol
Autors principals: Kim, Jae Hui, Chang, Young Suk, Kim, Jong Woo, Kim, Chul Gu, Lee, Dong Won
Format: Artigo
Idioma:Inglês
Publicat: International Journal of Ophthalmology Press 2019
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423401/
https://ncbi.nlm.nih.gov/pubmed/30918819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2019.03.20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars